UCSF helps faculty seek federal stimulus funds

The UCSF School of Pharmacy faculty and its UCSF faculty colleagues are being aided by the campus in their requests for funds provided to the National Institutes of Health (NIH) by the American Recovery and Reinvestment Act of 2009. The act, which was signed into law by U.S. President Barack Obama on February 17, 2009, allocates US$10.4 billion to the NIH of the total US$787 billion in federal economic stimulus funding. Helping coordinate and expedite UCSF faculty requests for funding is a new committee appointed by UCSF Chancellor J. Michael Bishop, MD, and chaired by School of Medicine researcher Jeffrey Bluestone, PhD. Bluestone is joined on the committee by Mary Anne-Koda Kimble, PharmD, and faculty and administrative colleagues from across UCSF.

Full story

UCSF Team to Devise Strategy for Going After NIH Stimulus Funds

Tags

Category:
Sites:
School of Pharmacy, Department of Pharmaceutical Chemistry, Department of Bioengineering and Therapeutic Sciences, Department of Clinical Pharmacy, PharmD Degree Program, Dean's Office

About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.